WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 3 fonti

Pfizer to seek FDA approval for Lyme disease vaccine candidate despite trial miss

Lyme disease is an illness caused by bacteria most commonly spread to humans from ticks. It can cause arthritis, muscle weakness and pain.

Raccontata dacnbc.comhuffpost.comusatoday.com

Confronto fonti

3 prospettive sulla stessa storia
AI · summaries
cnbc.comStai leggendo3 mesi fa

Pfizer to seek FDA approval for Lyme disease vaccine candidate despite trial miss

Lyme disease is an illness caused by bacteria most commonly spread to humans from ticks. It can cause arthritis, muscle weakness and pain.

originale
huffpost.com3 mesi fa

Pfizer Lyme Disease Vaccine Shows 70% Efficacy, But Misses Statistical Goal

The vaccine demonstrated a reduction in the rate of infections, but fell short of a key statistical requirement.

Leggi questa versione → originale

Timeline cronologica

  1. lunedì 23 marzo 2026·cnbc.com

    Pfizer to seek FDA approval for Lyme disease vaccine candidate despite trial miss

    Lyme disease is an illness caused by bacteria most commonly spread to humans from ticks. It can cause arthritis, muscle weakness and pain.

  2. martedì 24 marzo 2026·huffpost.com

    Pfizer Lyme Disease Vaccine Shows 70% Efficacy, But Misses Statistical Goal

    The vaccine demonstrated a reduction in the rate of infections, but fell short of a key statistical requirement.

usatoday.com3 mesi fa

Lyme disease vaccine shows strong results. How it works.

The first human Lyme disease vaccine was 73% effective against the tick-borne illness, says Pfizer. They still plan to seek approval.

Leggi questa versione → originale
  • mercoledì 25 marzo 2026·usatoday.com

    Lyme disease vaccine shows strong results. How it works.

    The first human Lyme disease vaccine was 73% effective against the tick-borne illness, says Pfizer. They still plan to seek approval.